Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEVANTE: Dose range-finding study of inhaled AZD8630 in uncontrolled asthma
jRCT2031240422Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2024
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Small Molecules, Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial of azd8630 in asthma (4 arms), sponsored by AstraZeneca. Primary endpoint: Time to first CompEx Asthma event. Started Jul 2024; status: completed.
02
Drugs
azd8630
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2031240422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240422.